{"id":3038,"date":"2024-10-11T19:10:28","date_gmt":"2024-10-11T17:10:28","guid":{"rendered":"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/"},"modified":"2024-10-11T19:10:28","modified_gmt":"2024-10-11T17:10:28","slug":"la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain","status":"publish","type":"post","link":"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/","title":{"rendered":"La filiale Opella, qui produit le Doliprane, bient\u00f4t rachet\u00e9e par un fonds am\u00e9ricain"},"content":{"rendered":"<p>Ce vendredi 11 octobre, le groupe pharmaceutique fran\u00e7ais Sanofi a confirm\u00e9 la tenue de n\u00e9gociations avec le fond am\u00e9ricain CD&amp;R pour le rachat de sa filiale Opella. Cette op\u00e9ration entra\u00eenerait le passage du Doliprane sous pavillon am\u00e9ricain.<br \/>\nL\u2019article La filiale Opella, qui produit le Doliprane, bient\u00f4t rachet\u00e9e par un fonds am\u00e9ricain est apparu en premier sur Portail de l&rsquo;IE.\u00a0<a href=\"https:\/\/www.portail-ie.fr\/univers\/enjeux-de-puissances-et-geoeconomie\/2024\/doliprane\/\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0Portail de l&rsquo;IE\u00a0<\/p>\n<p>\u200b\u00a0\u00a0<\/p>\n<p>\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p>Ce vendredi 11 octobre, le groupe pharmaceutique fran\u00e7ais Sanofi a confirm\u00e9 la tenue de n\u00e9gociations avec le fond am\u00e9ricain CD&amp;R pour le rachat de sa filiale Opella. Cette op\u00e9ration entra\u00eenerait le passage du Doliprane sous pavillon am\u00e9ricain. L\u2019article La filiale Opella, qui produit le Doliprane, bient\u00f4t rachet\u00e9e par un fonds am\u00e9ricain est apparu en premier&#8230;<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"footnotes":""},"categories":[12],"tags":[],"class_list":["post-3038","post","type-post","status-publish","format-standard","hentry","category-portail-de-lintelligence-economique"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La filiale Opella, qui produit le Doliprane, bient\u00f4t rachet\u00e9e par un fonds am\u00e9ricain - Revue Internationale d&#039;Intelligence Economique<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La filiale Opella, qui produit le Doliprane, bient\u00f4t rachet\u00e9e par un fonds am\u00e9ricain - Revue Internationale d&#039;Intelligence Economique\" \/>\n<meta property=\"og:description\" content=\"Ce vendredi 11 octobre, le groupe pharmaceutique fran\u00e7ais Sanofi a confirm\u00e9 la tenue de n\u00e9gociations avec le fond am\u00e9ricain CD&amp;R pour le rachat de sa filiale Opella. Cette op\u00e9ration entra\u00eenerait le passage du Doliprane sous pavillon am\u00e9ricain. L\u2019article La filiale Opella, qui produit le Doliprane, bient\u00f4t rachet\u00e9e par un fonds am\u00e9ricain est apparu en premier...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/\" \/>\n<meta property=\"og:site_name\" content=\"Revue Internationale d&#039;Intelligence Economique\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-11T17:10:28+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"La filiale Opella, qui produit le Doliprane, bient\u00f4t rachet\u00e9e par un fonds am\u00e9ricain\",\"datePublished\":\"2024-10-11T17:10:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/\"},\"wordCount\":91,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.r2ie.org\/#organization\"},\"articleSection\":[\"Portail de l'intelligence \u00e9conomique\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/\",\"url\":\"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/\",\"name\":\"La filiale Opella, qui produit le Doliprane, bient\u00f4t rachet\u00e9e par un fonds am\u00e9ricain - Revue Internationale d&#039;Intelligence Economique\",\"isPartOf\":{\"@id\":\"https:\/\/www.r2ie.org\/#website\"},\"datePublished\":\"2024-10-11T17:10:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.r2ie.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La filiale Opella, qui produit le Doliprane, bient\u00f4t rachet\u00e9e par un fonds am\u00e9ricain\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.r2ie.org\/#website\",\"url\":\"https:\/\/www.r2ie.org\/\",\"name\":\"Revue Internationale d&#039;Intelligence Economique\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.r2ie.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.r2ie.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.r2ie.org\/#organization\",\"name\":\"Revue Internationale d&#039;Intelligence Economique\",\"url\":\"https:\/\/www.r2ie.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.r2ie.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.r2ie.org\/wp-content\/uploads\/2023\/01\/cropped-cropped-logo-r2ie-dc3a9gradc3a9.webp\",\"contentUrl\":\"https:\/\/www.r2ie.org\/wp-content\/uploads\/2023\/01\/cropped-cropped-logo-r2ie-dc3a9gradc3a9.webp\",\"width\":654,\"height\":251,\"caption\":\"Revue Internationale d&#039;Intelligence Economique\"},\"image\":{\"@id\":\"https:\/\/www.r2ie.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La filiale Opella, qui produit le Doliprane, bient\u00f4t rachet\u00e9e par un fonds am\u00e9ricain - Revue Internationale d&#039;Intelligence Economique","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/","og_locale":"fr_FR","og_type":"article","og_title":"La filiale Opella, qui produit le Doliprane, bient\u00f4t rachet\u00e9e par un fonds am\u00e9ricain - Revue Internationale d&#039;Intelligence Economique","og_description":"Ce vendredi 11 octobre, le groupe pharmaceutique fran\u00e7ais Sanofi a confirm\u00e9 la tenue de n\u00e9gociations avec le fond am\u00e9ricain CD&amp;R pour le rachat de sa filiale Opella. Cette op\u00e9ration entra\u00eenerait le passage du Doliprane sous pavillon am\u00e9ricain. L\u2019article La filiale Opella, qui produit le Doliprane, bient\u00f4t rachet\u00e9e par un fonds am\u00e9ricain est apparu en premier...","og_url":"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/","og_site_name":"Revue Internationale d&#039;Intelligence Economique","article_published_time":"2024-10-11T17:10:28+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/#article","isPartOf":{"@id":"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/"},"author":{"name":"","@id":""},"headline":"La filiale Opella, qui produit le Doliprane, bient\u00f4t rachet\u00e9e par un fonds am\u00e9ricain","datePublished":"2024-10-11T17:10:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/"},"wordCount":91,"commentCount":0,"publisher":{"@id":"https:\/\/www.r2ie.org\/#organization"},"articleSection":["Portail de l'intelligence \u00e9conomique"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/","url":"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/","name":"La filiale Opella, qui produit le Doliprane, bient\u00f4t rachet\u00e9e par un fonds am\u00e9ricain - Revue Internationale d&#039;Intelligence Economique","isPartOf":{"@id":"https:\/\/www.r2ie.org\/#website"},"datePublished":"2024-10-11T17:10:28+00:00","breadcrumb":{"@id":"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.r2ie.org\/index.php\/2024\/10\/11\/la-filiale-opella-qui-produit-le-doliprane-bientot-rachetee-par-un-fonds-americain\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.r2ie.org\/"},{"@type":"ListItem","position":2,"name":"La filiale Opella, qui produit le Doliprane, bient\u00f4t rachet\u00e9e par un fonds am\u00e9ricain"}]},{"@type":"WebSite","@id":"https:\/\/www.r2ie.org\/#website","url":"https:\/\/www.r2ie.org\/","name":"Revue Internationale d&#039;Intelligence Economique","description":"","publisher":{"@id":"https:\/\/www.r2ie.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.r2ie.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.r2ie.org\/#organization","name":"Revue Internationale d&#039;Intelligence Economique","url":"https:\/\/www.r2ie.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.r2ie.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.r2ie.org\/wp-content\/uploads\/2023\/01\/cropped-cropped-logo-r2ie-dc3a9gradc3a9.webp","contentUrl":"https:\/\/www.r2ie.org\/wp-content\/uploads\/2023\/01\/cropped-cropped-logo-r2ie-dc3a9gradc3a9.webp","width":654,"height":251,"caption":"Revue Internationale d&#039;Intelligence Economique"},"image":{"@id":"https:\/\/www.r2ie.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.r2ie.org\/index.php\/wp-json\/wp\/v2\/posts\/3038","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.r2ie.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.r2ie.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.r2ie.org\/index.php\/wp-json\/wp\/v2\/comments?post=3038"}],"version-history":[{"count":0,"href":"https:\/\/www.r2ie.org\/index.php\/wp-json\/wp\/v2\/posts\/3038\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.r2ie.org\/index.php\/wp-json\/wp\/v2\/media?parent=3038"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.r2ie.org\/index.php\/wp-json\/wp\/v2\/categories?post=3038"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.r2ie.org\/index.php\/wp-json\/wp\/v2\/tags?post=3038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}